Coagulopathy (main): Difference between revisions
No edit summary |
Elcatracho (talk | contribs) |
||
| (6 intermediate revisions by 3 users not shown) | |||
| Line 5: | Line 5: | ||
==Clinical Features== | ==Clinical Features== | ||
*Spontaneous bleeding | *Spontaneous [[hemorrhage|bleeding]] | ||
*Bleeding out of proportion | *Bleeding out of proportion | ||
*Swollen joints | *Swollen joints | ||
*[[Epistaxis]] | *[[Epistaxis]] | ||
*Bleeding gums | *Bleeding gums | ||
*Menometrorrhagia | *[[vaginal Bleed Non-Pregnant|Menometrorrhagia]] | ||
*Easy bruising/petechiae | *Easy bruising/[[petechiae]] | ||
*Hematuria | *[[Hematuria]] | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
| Line 18: | Line 18: | ||
===Increased Clotting=== | ===Increased Clotting=== | ||
{{Increased clotting DDX}} | |||
== | |||
==Management== | |||
*[[Bleeding Treatments]] | *[[Bleeding Treatments]] | ||
*[[Procedures in patients with coagulopathies]] | *[[Procedures in patients with coagulopathies]] | ||
| Line 32: | Line 33: | ||
*[[Transfusions]] | *[[Transfusions]] | ||
*[[Idarucizumab]] | *[[Idarucizumab]] | ||
*[[Procedures in patients with coagulopathies]] | |||
==References== | ==References== | ||
<references/> | |||
[[Category:Heme/Onc]] | [[Category:Heme/Onc]] | ||
Latest revision as of 18:15, 17 February 2021
Background
- Primary hemostasis: damage to endothelial basement membrane and formation of platelet plug
- Secondary hemostasis: coagulation cascade
Clinical Features
- Spontaneous bleeding
- Bleeding out of proportion
- Swollen joints
- Epistaxis
- Bleeding gums
- Menometrorrhagia
- Easy bruising/petechiae
- Hematuria
Differential Diagnosis
Coagulopathy
Platelet Related
- Too few
- Nonfunctional
Factor Related
- Acquired (Drug Related)
- Warfarin (Coumadin)
- Unfractionated heparin
- Low molecular weight heparin (i.e. enoxaparin (Lovenox), dalteparin)
- Factor Xa Inhibitors (e.g. rivaroxaban, apixaban, fondaparinux, edoxaban)
- Direct thrombin inhibitors (e.g. dabigatran, argatroban, bivalirudin)
- Illness induced
- Genetic
Increased Clotting
Management
- Bleeding Treatments
- Procedures in patients with coagulopathies
- Anticoagulant reversal (known medications)
- Anti-platelet agent reversal